This approach will help ensure that the local manufacturing of diagnostic imaging equipment remains economically viable and financially sustainable over the coming years.
Through this acquisition, Philips aims to enhance the precision and efficiency of coronary interventions, ultimately benefiting both healthcare professionals and patients.
Philips has pioneered this detector-based spectral CT approach that produces multiple spectral outputs from a single scan without sacrificing performance or increasing scan time.
LumiGuide enables physicians to visualize and guide devices inside the body using light instead of continuous X-ray imaging.
Philips has pioneered helium-free MRI technology, installing over 2,000 of its 1.5T BlueSeal MRI systems globally and conserving more than 6 million liters of liquid helium.
The partnership combines Philips’ next-generation MR technology with Cortechs.ai’s AI-driven quantitative neuroimaging software to transform how doctors detect, monitor, and manage neurological diseases.